{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:16:56Z","timestamp":1791818216041,"version":"4.3.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313560"],"award-info":[{"award-number":["2018A030313560"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acute myeloid leukemia (AML) is a fatal disease characterized by the accumulation of immature myeloid blasts in the bone marrow (BM). Cytokine provide signals for leukemia cells to improve their survival in the BM microenvironment. Previously, we identified interleukin-33 (IL-33) as a promoter of cell survival in a human AML cell line and primary mouse leukemia cells. In this study, we report that the cell surface expression of IL-33\u2013specific receptor, Interleukin 1 Receptor Like 1 (IL1RL1), is elevated in BM cells from AML patients at diagnosis, and the serum level of IL-33 in AML patients is higher than that of healthy donor controls. Moreover, IL-33 levels are found to be positively associated with IL-6 levels in pediatric patients with AML. <jats:italic>In vitro<\/jats:italic>, IL-33 treatment increased IL-6 mRNA expression and protein level in BM and peripheral blood (PB) cells from AML patients. Evidence was also provided that IL-33 inhibits cell apoptosis by activating p38 mitogen-activated protein kinase (MAPK) pathway using human AML cell line and AML patient samples. Finally, we confirmed that IL-33 activated IL-6 expression in a manner that required p38 MAPK pathway using clinical AML samples. Taken together, we identified a potential mechanism of IL-33\u2013mediated survival involving p38 MAPK in pediatric AML patients that would facilitate future drug development.<\/jats:p>","DOI":"10.3389\/fimmu.2020.595053","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T05:42:57Z","timestamp":1606369377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Interleukin-33 Promotes Cell Survival via p38 MAPK-Mediated Interleukin-6 Gene Expression and Release in Pediatric AML"],"prefix":"10.3389","volume":"11","author":[{"given":"Yiqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70090-5","article-title":"Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial","volume":"11","author":"Rubnitz","year":"2010","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22612","article-title":"Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study","volume":"55","author":"Gorman","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4040665","article-title":"Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia","volume":"4","author":"Ramos","year":"2015","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040840","article-title":"Targeting Tumor Microenvironment for Cancer Therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4660","article-title":"Role of the tumor microenvironment in tumor progression and the clinical applications (Review)","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-351742","article-title":"Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity","volume":"118","author":"Elsawa","year":"2011","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3184","article-title":"Dynamic niches in the origination and differentiation of haematopoietic stem cells","volume":"12","author":"Wang","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00444","article-title":"Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look","volume":"8","author":"Behrmann","year":"2018","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-202606","article-title":"The leukemic stem cell niche: current concepts and therapeutic opportunities","volume":"114","author":"Lane","year":"2009","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.109","article-title":"Functional integration of acute myeloid leukemia into the vascular niche","volume":"28","author":"Cogle","year":"2014","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2014.958464","article-title":"The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment","volume":"7","author":"Isidori","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2797","article-title":"BCR-ABL-induced deregulation of the IL-33\/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients","volume":"74","author":"Levescot","year":"2014","journal-title":"Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401344","article-title":"Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells","volume":"194","author":"Gao","year":"2015","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1063772","article-title":"Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells","volume":"5","author":"Xiao","year":"2016","journal-title":"Oncoimmunology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/s41598-018-38408-3","article-title":"IL1RL1 is dynamically expressed on Cbfb-MYH11(+) leukemia stem cells and promotes cell survival","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-227413","article-title":"Cbfb\/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11","volume":"115","author":"Hyde","year":"2010","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"106409","DOI":"10.1016\/j.leukres.2020.106409","article-title":"IL-33\/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia","volume":"96","author":"Wang","year":"2020","journal-title":"Leuk Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1182\/blood-2008-03-143735","article-title":"WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)","volume":"112","author":"Alessandrino","year":"2008","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12462","article-title":"17beta-estradiol ameliorates age-associated loss of fibroblast function by attenuating IFN-gamma\/STAT1-dependent miR-7 upregulation","volume":"15","author":"Midgley","year":"2016","journal-title":"Aging Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3439","article-title":"Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications","volume":"48","author":"Poniewierska-Baran","year":"2016","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.immuni.2015.01.016","article-title":"The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway","volume":"42","author":"Endo","year":"2015","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000430188","article-title":"Impact of p38 MAP Kinase Inhibitors on LPS-Induced Release of TNF-alpha in Whole Blood and Primary Cells from Different Species","volume":"36","author":"Fehr","year":"2015","journal-title":"Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00463","article-title":"Targeted Therapies for Pediatric AML: Gaps and Perspective","volume":"7","author":"Lonetti","year":"2019","journal-title":"Front Pediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12459","article-title":"Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia","volume":"105","author":"Han","year":"2014","journal-title":"Cancer Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017007856","article-title":"Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance","volume":"1","author":"Stevens","year":"2017","journal-title":"Blood Adv"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163751","article-title":"IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF","volume":"11","author":"Willebrand","year":"2016","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","article-title":"Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling","volume":"2","author":"Seki","year":"2009","journal-title":"Circ Heart Failure"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00423","article-title":"IL-33 Provides Neuroprotection through Suppressing Apoptotic, Autophagic and NF-kappaB-Mediated Inflammatory Pathways in a Rat Model of Recurrent Neonatal Seizure","volume":"10","author":"Gao","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00898","article-title":"IL-33 Alleviated Brain Damage via Anti-apoptosis, Endoplasmic Reticulum Stress, and Inflammation After Epilepsy","volume":"14","author":"Gao","year":"2020","journal-title":"Front Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1038\/s41598-020-60089-0","article-title":"p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells","volume":"10","author":"Petrova","year":"2020","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3A0120-379RR","article-title":"IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells","volume":"107","author":"Ochayon","year":"2020","journal-title":"J Leukocyte Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.02.008","article-title":"Effects of interleukin-33 on cardiac fibroblast gene expression and activity","volume":"58","author":"Zhu","year":"2012","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2007.09.013","article-title":"Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells","volume":"40","author":"Moulin","year":"2007","journal-title":"Cytokine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2008.05.013","article-title":"TRAF6 is a critical signal transducer in IL-33 signaling pathway","volume":"20","author":"Funakoshi-Tago","year":"2008","journal-title":"Cell Signal"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600658","article-title":"MK2\/3 Are Pivotal for IL-33-Induced and Mast Cell-Dependent Leukocyte Recruitment and the Resulting Skin Inflammation","volume":"197","author":"Drube","year":"2016","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1454","article-title":"Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase","volume":"263","author":"Kumar","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000083490.43943.85","article-title":"Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia","volume":"93","author":"Tanno","year":"2003","journal-title":"Circ Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.1067289","article-title":"MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha","volume":"295","author":"Ge","year":"2002","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc2681","article-title":"Emerging roles of ATF2 and the dynamic AP1 network in cancer","volume":"10","author":"Lopez-Bergami","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.02.004","article-title":"ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease","volume":"119","author":"Watson","year":"2017","journal-title":"Pharmacol Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3858\/emm.2008.40.6.699","article-title":"Transcription of the protein kinase C-delta gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin","volume":"40","author":"Min","year":"2008","journal-title":"Exp Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.595053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T05:42:58Z","timestamp":1606369378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.595053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2020.595053"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.595053","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"article-number":"595053"}}